Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H18O |
| Molecular Weight | 154.2493 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1CC[C@H]([C@H](O)C1)C(C)=C
InChI
InChIKey=ZYTMANIQRDEHIO-KXUCPTDWSA-N
InChI=1S/C10H18O/c1-7(2)9-5-4-8(3)6-10(9)11/h8-11H,1,4-6H2,2-3H3/t8-,9+,10-/m1/s1
| Molecular Formula | C10H18O |
| Molecular Weight | 154.2493 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: possible involvement of GABAergic system and antioxidant activity. | 2009-12 |
|
| Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. | 2004-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:06:36 GMT 2025
by
admin
on
Mon Mar 31 19:06:36 GMT 2025
|
| Record UNII |
3TH92O3BXN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
||
|
JECFA EVALUATION |
ISOPULEGOL
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
615
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
DTXSID5047116
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
231369
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
201-940-6
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
1314235
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | RxNorm | ||
|
7786-67-6
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
89-79-2
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
100000159679
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
170833
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
3TH92O3BXN
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
C409816
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
3TH92O3BXN
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY | |||
|
SUB170054
Created by
admin on Mon Mar 31 19:06:36 GMT 2025 , Edited by admin on Mon Mar 31 19:06:36 GMT 2025
|
PRIMARY |